As a pharmaceutical company specializing in cancer treatment, Kechow Pharma has developed a unique R&D pipeline driven by its deep knowledge and understanding of oncology.

Kechow Pharma prioritizes innovation and fosters a "science-driven" corporate culture. It currently has several products in development, including a series of highly selective small-molecule compounds based on chemistry-oriented drug discovery and development. Compared to existing drugs, our candidate drugs exhibit superior drug properties, positioning them with the potential to become the next generation of best-in-class targeted therapies globally.